Found 57 Breast Cancer trials
A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
This study investigates the effectiveness of the "Just ASK" training program in enhancing discussions about breast cancer clinical trials between healthcare providers and patients. The purpose of this study is to evaluate if the training can increase the frequency and quality of these discussions, which are crucial for patient enrollment …
This study investigates the effects of investigational medications like hydroxychloroquine and avelumab, with or without palbociclib, on early-stage ER+ breast cancer patients. These patients have disseminated tumor cells (DTCs) in their bone marrow after surgery and standard therapy. The purpose is to understand how these medications can target DTCs, which …
This study investigates different dosing strategies for CDK4/6 inhibitors in older patients with metastatic breast cancer (MBC). The purpose of the study is to compare standard dosing with a titrated dosing approach to see which helps patients tolerate the medication better and continue treatment longer.Participants will be randomly assigned to …
This study investigates the effects of using investigational medications to target minimal residual disease in patients with breast cancer. The purpose of this study is to see if the investigational medications can reduce or eliminate disseminated tumor cells in the bone marrow.Participants in this study will take investigational medications in …
This study investigates breast cancer. It looks at the effects of an investigational medication given before surgery.The purpose of this study is to evaluate the safety and immune effects of the investigational medication. The study will check how the body responds to the treatment.Who can participate: Adults aged 18 and …
The purpose of this study is to investigate locally advanced or metastatic estrogen receptor-positive, HER2-negative breast cancer. This study investigates how the investigational medication performs alone and when combined with another treatment.This study evaluates the safety and how well the investigational medication works. It looks at how the investigational medication …
This study will compare the good and bad effects of not giving regional radiotherapy versus using regional radiotherapy in patients with low risk breast cancer as indicated by Oncotype DX Recurrence Score. This is intended to help researchers discover if not giving regional radiotherapy will be as beneficial as using …
We propose an iterative approach to develop and pilot test a new mHealth behavioral intervention for AET adherence that is culturally tailored to Black breast cancer survivors. We will first use qualitative methods informed by Black breast cancer survivors to develop a blueprint of the intervention (Aim 1). We will …
This study investigates the safety and tolerability of an investigational medication for women with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer. The study focuses on participants whose tumors have mutations in the PIK3CA gene. The purpose is to find the safest and …
This study investigates the effectiveness of investigational medications for patients with advanced breast cancer who have specific genetic mutations. The purpose of this study is to compare the effects of saruparib plus camizestrant with other treatments chosen by the physician, including CDK4/6 inhibitors and endocrine therapy. The study focuses on …
Please choose between Voice or SMS based delivery of verification code
or